Clinical outcomes of drug-coated balloon for treatment of de novo coronary artery disease with and without diabetes

Zhaoqian Zhang; Qiang Tan; Jiarui Zhang; Xinhui Wang; Qian Wang

doi:10.15537/smj.2022.43.12.20220534

References

1.↵
1. Khan R,
2. Chua ZJY,
3. Tan JC,
4. Yang Y,
5. Liao Z,
6. Zhao Y.
From pre-diabetes to diabetes: diagnosis, treatments and translational research. Medicina (Kaunas) 2019; 55: 546.
OpenUrl
2.↵
1. Wilson S,
2. Mone P,
3. Kansakar U,
4. Jankauskas SS,
5. Donkor K,
6. Adebayo A
, Vet al. Diabetes and restenosis. Cardiovasc Diabetol 2022; 21: 23.
OpenUrl
3.↵
1. Konigstein M,
2. Ben-Yehuda O,
3. Smits PC,
4. Love MP,
5. Banai S,
6. Perlman GY, et al.
Outcomes among diabetic patients undergoing percutaneous coronary intervention with contem porary drug-eluting stents: analysis from the BIONICS randomized trial. J Am Coll Cardiol Intv 2018; 11: 2467–2476.
OpenUrl
4.↵
1. Ploumen EH,
2. Pinxterhuis TH,
3. Zocca P,
4. Roguin A,
5. Anthonio RL,
6. Schotborgh CE, et al.
Impact of prediabetes and diabetes on 3-year outcome of patients treated with new-generation drug-eluting stents in two large-scale randomized clinical trials. Cardiovasc Diabetol 2021; 20: 217
OpenUrl
5.↵
1. Baan J,
2. Claessen B E,
3. Dijk K B,
4. Vendrik J,
5. van der Schaaf RJ,
6. Meuwissen M, et al.
A randomized comparison of paclitaxel-eluting balloon versus everolimus-eluting stent for the treatment of any in-stent restenosis. The DARE trial. J Am Coll Cardiol Intv 2018; 11: 275–283.
OpenUrl
6.↵
1. Beulens J,
2. Rutters F,
3. Rydén L,
4. Schnell O,
5. Mellbin L,
6. Hart HE, et al.
Risk and management of pre-diabetes. Eur J Prev Cardiol 2019; 26: 47–54.
OpenUrl CrossRef PubMed
7.↵
1. Giannini F,
2. Latib A,
3. Jabbour RJ,
4. Costopoulos C,
5. Chieffo A,
6. Carlino M, et al.
Comparison of paclitaxel drug-eluting balloon and paclitaxel-eluting stent in small coronary vessels in diabetic and nondiabetic patients—results from the BELLO (balloon elution and late loss optimization) trial. Cardiovasc Revascul Med 2017; 18: 4–9.
OpenUrl
8.↵
1. Sinaga DA,
2. Ho HH,
3. Watson TJ,
4. Sim A,
5. Nyein TT,
6. Jafary FH, et al.
Drug-coated balloons: a safe and effective alternative to drug-eluting stents in small vessel coronary artery disease. J Interv Cardiol 2016; 29: 454–460.
OpenUrl
9.↵
1. Mohiaddin H,
2. Wong TD,
3. Burke-Gaffney A,
4. Bogle RG.
Drug-coated balloon-only percutaneous coronary intervention for the treatment of de novo coronary artery disease: a systematic review. Cardiol Ther 2018; 7: 127–149.
OpenUrl
10.↵
American Diabetes Association. (2) Classification and diagnosis of diabetes. Diabetes Care 2015; 38: S8–S16.
OpenUrl FREE Full Text
11.↵
1. Tan Q,
2. Chen M,
3. Hao J,
4. Wei K.
Impact of hyperinsulinemia on long-term clinical outcomes of percutaneous coronary intervention in patients without diabetes who have acute myocardial syndrome. Diabetes Metab Syndr Obes 2021; 7: 3949–3957.
OpenUrl
12.↵
1. Kok MM,
2. von Birgelen C,
3. Sattar N,
4. Zocca P,
5. Lowik MM,
6. Danse PW, et al.
Prediabetes and its impact on clinical outcome after coronary intervention in a broad patient population. EuroIntervention 2018; 14: e1049–e1056.
OpenUrl
13.↵
1. Kim YH,
2. Her AY,
3. Jeong MH,
4. Kim BK,
5. Hong SJ,
6. Kim S, et al.
Efects of prediabetes on long-term clinical outcomes of patients with acute myocardial infarction who underwent PCI using new-generation drug-eluting stents. Diabetes Res Clin Pract 2020; 160: 107994.
OpenUrl
14.↵
1. Kim YH,
2. Her AY,
3. Jeong MH,
4. Kim BK,
5. Hong SJ,
6. Kim S, et al.
Effect of renin-angiotensin system inhibitors on major clinical outcomes in patients with acute myocardial infarction and prediabetes or diabetes after successful implantation of newer-generation drug-eluting stents. J Diabetes Complications 2020; 34: 107574
OpenUrl
15.↵
1. Kufner S,
2. Cassese S,
3. Valeskini M,
4. Neumann F,
5. Schulz-Schüpke S,
6. Hoppmann P, et al.
Long-term efficacy and safety of paclitaxel-eluting balloon for the treatment of drug-eluting stent restenosis 3-year results of a randomized controlled trial. J Am Coll Cardiol Intv 2015; 8: 877–8415.
OpenUrl
16.↵
1. Picard F,
2. Doucet S,
3. Asgar AW.
Contemporary use of drug-coated balloons in coronary artery disease: where are we now? Arch Cardiovasc Dis 2017; 110: 259–272.
OpenUrl
17.↵
1. Pan L,
2. Lu W,
3. Han Z,
4. Pan S,
5. Wang X,
6. Shan Y, et al.
Clinical outcomes of drug-coated balloon in coronary patients with and without diabetes mellitus: a multicenter, propensity score study. J Diabetes Res 2021; 29; 2021: 5495219
OpenUrl
18.↵
1. Jarrah MI,
2. Al-Khatib S,
3. Khader Y,
4. AlKharabsheh HN,
5. Hammoudeh A,
6. Alzoubi KH, et al.
The impact of coexistence of smoking and diabetes on the coronary artery severity and outcomes following percutaneous coronary intervention: Results from the 1ST Jordanian PCI Registry. Int J Vasc Med 2020; 2; 2020: 762415818.
OpenUrl
19.↵
1. Zhao X,
2. Lan J,
3. Yu X,
4. Zhou J,
5. Tan Y,
6. Sheng Z, et al.
Primary percutaneous coronary intervention in patients with type 2 diabetes with late/very late stent thrombosis and de novo lesions: A single-center observational cohort study of clinical outcomes and influencing factors. Front Cardiovasc Med 2021; 8: 653467
OpenUrl
20.↵
1. Tan Q,
2. Qiu L,
3. Li G,
4. Li C,
5. Zheng C,
6. Meng H, et al.
Transplantation of healthy but not diabetic outgrowth endothelial cells could rescue ischemic myocardium in diabetic rabbits. Scand J Clin Lab Invest 2010; 70: 313–321
21.↵
1. Tan Q,
2. Li Y,
3. Li X,
4. Zhang S.
Hyperinsulinemia impairs functions of circulating endothelial progenitor cells. Acta Diabetol 2019; 56: 785–795.
OpenUrl
22.↵
1. Choi J H,
2. Gimble J M,
3. Vunjak-Novakovic G,
4. Kaplan D L.
Effects of hyperinsulinemia on lipolytic function of three-dimensional adipocyte endothelial co-cultures. Tissue Eng Part C Methods 2010; 16: 1157–1165.
OpenUrl PubMed
23.↵
1. Halim M,
2. Halim A.
The effects of inflammation, aging and oxidative stress on the pathogenesis of diabetes mellitus (type 2 diabetes). Diabetes Metab Syndr 2019; 13: 1165–1172.
OpenUrl

In this issue

Download PDF

Email Article

Citation Tools

Bookmark this article

Cited By...

No citing articles found.

Google Scholar

More in this TOC Section

Show more Original Article

Keywords

[1] 1.↵
Khan R,
Chua ZJY,
Tan JC,
Yang Y,
Liao Z,
Zhao Y.
From pre-diabetes to diabetes: diagnosis, treatments and translational research. Medicina (Kaunas) 2019; 55: 546.
OpenUrl

[2] Khan R,

[3] Chua ZJY,

[4] Tan JC,

[5] Yang Y,

[6] Liao Z,

[7] Zhao Y.

[8] 2.↵
Wilson S,
Mone P,
Kansakar U,
Jankauskas SS,
Donkor K,
Adebayo A
, Vet al. Diabetes and restenosis. Cardiovasc Diabetol 2022; 21: 23.
OpenUrl

[9] Wilson S,

[10] Mone P,

[11] Kansakar U,

[12] Jankauskas SS,

[13] Donkor K,

[14] Adebayo A

[15] 3.↵
Konigstein M,
Ben-Yehuda O,
Smits PC,
Love MP,
Banai S,
Perlman GY, et al.
Outcomes among diabetic patients undergoing percutaneous coronary intervention with contem porary drug-eluting stents: analysis from the BIONICS randomized trial. J Am Coll Cardiol Intv 2018; 11: 2467–2476.
OpenUrl

[16] Konigstein M,

[17] Ben-Yehuda O,

[18] Smits PC,

[19] Love MP,

[20] Banai S,

[21] Perlman GY, et al.

[22] 4.↵
Ploumen EH,
Pinxterhuis TH,
Zocca P,
Roguin A,
Anthonio RL,
Schotborgh CE, et al.
Impact of prediabetes and diabetes on 3-year outcome of patients treated with new-generation drug-eluting stents in two large-scale randomized clinical trials. Cardiovasc Diabetol 2021; 20: 217
OpenUrl

[23] Ploumen EH,

[24] Pinxterhuis TH,

[25] Zocca P,

[26] Roguin A,

[27] Anthonio RL,

[28] Schotborgh CE, et al.

[29] 5.↵
Baan J,
Claessen B E,
Dijk K B,
Vendrik J,
van der Schaaf RJ,
Meuwissen M, et al.
A randomized comparison of paclitaxel-eluting balloon versus everolimus-eluting stent for the treatment of any in-stent restenosis. The DARE trial. J Am Coll Cardiol Intv 2018; 11: 275–283.
OpenUrl

[30] Baan J,

[31] Claessen B E,

[32] Dijk K B,

[33] Vendrik J,

[34] van der Schaaf RJ,

[35] Meuwissen M, et al.

[36] 6.↵
Beulens J,
Rutters F,
Rydén L,
Schnell O,
Mellbin L,
Hart HE, et al.
Risk and management of pre-diabetes. Eur J Prev Cardiol 2019; 26: 47–54.
OpenUrl CrossRef PubMed

[37] Beulens J,

[38] Rutters F,

[39] Rydén L,

[40] Schnell O,

[41] Mellbin L,

[42] Hart HE, et al.

[43] 7.↵
Giannini F,
Latib A,
Jabbour RJ,
Costopoulos C,
Chieffo A,
Carlino M, et al.
Comparison of paclitaxel drug-eluting balloon and paclitaxel-eluting stent in small coronary vessels in diabetic and nondiabetic patients—results from the BELLO (balloon elution and late loss optimization) trial. Cardiovasc Revascul Med 2017; 18: 4–9.
OpenUrl

[44] Giannini F,

[45] Latib A,

[46] Jabbour RJ,

[47] Costopoulos C,

[48] Chieffo A,

[49] Carlino M, et al.

[50] 8.↵
Sinaga DA,
Ho HH,
Watson TJ,
Sim A,
Nyein TT,
Jafary FH, et al.
Drug-coated balloons: a safe and effective alternative to drug-eluting stents in small vessel coronary artery disease. J Interv Cardiol 2016; 29: 454–460.
OpenUrl

[51] Sinaga DA,

[52] Ho HH,

[53] Watson TJ,

[54] Sim A,

[55] Nyein TT,

[56] Jafary FH, et al.

[57] 9.↵
Mohiaddin H,
Wong TD,
Burke-Gaffney A,
Bogle RG.
Drug-coated balloon-only percutaneous coronary intervention for the treatment of de novo coronary artery disease: a systematic review. Cardiol Ther 2018; 7: 127–149.
OpenUrl

[58] Mohiaddin H,

[59] Wong TD,

[60] Burke-Gaffney A,

[61] Bogle RG.

[62] 10.↵
American Diabetes Association. (2) Classification and diagnosis of diabetes. Diabetes Care 2015; 38: S8–S16.
OpenUrl FREE Full Text

[63] 11.↵
Tan Q,
Chen M,
Hao J,
Wei K.
Impact of hyperinsulinemia on long-term clinical outcomes of percutaneous coronary intervention in patients without diabetes who have acute myocardial syndrome. Diabetes Metab Syndr Obes 2021; 7: 3949–3957.
OpenUrl

[64] Tan Q,

[65] Chen M,

[66] Hao J,

[67] Wei K.

[68] 12.↵
Kok MM,
von Birgelen C,
Sattar N,
Zocca P,
Lowik MM,
Danse PW, et al.
Prediabetes and its impact on clinical outcome after coronary intervention in a broad patient population. EuroIntervention 2018; 14: e1049–e1056.
OpenUrl

[69] Kok MM,

[70] von Birgelen C,

[71] Sattar N,

[72] Zocca P,

[73] Lowik MM,

[74] Danse PW, et al.

[75] 13.↵
Kim YH,
Her AY,
Jeong MH,
Kim BK,
Hong SJ,
Kim S, et al.
Efects of prediabetes on long-term clinical outcomes of patients with acute myocardial infarction who underwent PCI using new-generation drug-eluting stents. Diabetes Res Clin Pract 2020; 160: 107994.
OpenUrl

[76] Kim YH,

[77] Her AY,

[78] Jeong MH,

[79] Kim BK,

[80] Hong SJ,

[81] Kim S, et al.

[82] 14.↵
Kim YH,
Her AY,
Jeong MH,
Kim BK,
Hong SJ,
Kim S, et al.
Effect of renin-angiotensin system inhibitors on major clinical outcomes in patients with acute myocardial infarction and prediabetes or diabetes after successful implantation of newer-generation drug-eluting stents. J Diabetes Complications 2020; 34: 107574
OpenUrl

[83] Kim YH,

[84] Her AY,

[85] Jeong MH,

[86] Kim BK,

[87] Hong SJ,

[88] Kim S, et al.

[89] 15.↵
Kufner S,
Cassese S,
Valeskini M,
Neumann F,
Schulz-Schüpke S,
Hoppmann P, et al.
Long-term efficacy and safety of paclitaxel-eluting balloon for the treatment of drug-eluting stent restenosis 3-year results of a randomized controlled trial. J Am Coll Cardiol Intv 2015; 8: 877–8415.
OpenUrl

[90] Kufner S,

[91] Cassese S,

[92] Valeskini M,

[93] Neumann F,

[94] Schulz-Schüpke S,

[95] Hoppmann P, et al.

[96] 16.↵
Picard F,
Doucet S,
Asgar AW.
Contemporary use of drug-coated balloons in coronary artery disease: where are we now? Arch Cardiovasc Dis 2017; 110: 259–272.
OpenUrl

[97] Picard F,

[98] Doucet S,

[99] Asgar AW.

[100] 17.↵
Pan L,
Lu W,
Han Z,
Pan S,
Wang X,
Shan Y, et al.
Clinical outcomes of drug-coated balloon in coronary patients with and without diabetes mellitus: a multicenter, propensity score study. J Diabetes Res 2021; 29; 2021: 5495219
OpenUrl

[101] Pan L,

[102] Lu W,

[103] Han Z,

[104] Pan S,

[105] Wang X,

[106] Shan Y, et al.

[107] 18.↵
Jarrah MI,
Al-Khatib S,
Khader Y,
AlKharabsheh HN,
Hammoudeh A,
Alzoubi KH, et al.
The impact of coexistence of smoking and diabetes on the coronary artery severity and outcomes following percutaneous coronary intervention: Results from the 1ST Jordanian PCI Registry. Int J Vasc Med 2020; 2; 2020: 762415818.
OpenUrl

[108] Jarrah MI,

[109] Al-Khatib S,

[110] Khader Y,

[111] AlKharabsheh HN,

[112] Hammoudeh A,

[113] Alzoubi KH, et al.

[114] 19.↵
Zhao X,
Lan J,
Yu X,
Zhou J,
Tan Y,
Sheng Z, et al.
Primary percutaneous coronary intervention in patients with type 2 diabetes with late/very late stent thrombosis and de novo lesions: A single-center observational cohort study of clinical outcomes and influencing factors. Front Cardiovasc Med 2021; 8: 653467
OpenUrl

[115] Zhao X,

[116] Lan J,

[117] Yu X,

[118] Zhou J,

[119] Tan Y,

[120] Sheng Z, et al.

[121] 20.↵
Tan Q,
Qiu L,
Li G,
Li C,
Zheng C,
Meng H, et al.
Transplantation of healthy but not diabetic outgrowth endothelial cells could rescue ischemic myocardium in diabetic rabbits. Scand J Clin Lab Invest 2010; 70: 313–321

[122] Tan Q,

[123] Qiu L,

[124] Li G,

[125] Li C,

[126] Zheng C,

[127] Meng H, et al.

[128] 21.↵
Tan Q,
Li Y,
Li X,
Zhang S.
Hyperinsulinemia impairs functions of circulating endothelial progenitor cells. Acta Diabetol 2019; 56: 785–795.
OpenUrl

[129] Tan Q,

[130] Li Y,

[131] Li X,

[132] Zhang S.

[133] 22.↵
Choi J H,
Gimble J M,
Vunjak-Novakovic G,
Kaplan D L.
Effects of hyperinsulinemia on lipolytic function of three-dimensional adipocyte endothelial co-cultures. Tissue Eng Part C Methods 2010; 16: 1157–1165.
OpenUrl PubMed

[134] Choi J H,

[135] Gimble J M,

[136] Vunjak-Novakovic G,

[137] Kaplan D L.

[138] 23.↵
Halim M,
Halim A.
The effects of inflammation, aging and oxidative stress on the pathogenesis of diabetes mellitus (type 2 diabetes). Diabetes Metab Syndr 2019; 13: 1165–1172.
OpenUrl

[139] Halim M,

[140] Halim A.

Main menu

User menu

Search

Clinical outcomes of drug-coated balloon for treatment of de novo coronary artery disease with and without diabetes

References

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords

CONTENT

JOURNAL

AUTHORS

Main menu

User menu

Search

Clinical outcomes of drug-coated balloon for treatment of de novo coronary artery disease with and without diabetes

References

In this issue

Citation Manager Formats

Jump to section

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords

CONTENT

JOURNAL

AUTHORS